Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry

References

• Best JG, Bell R, Haque M, Chandratheva A, Werring DJ. Atrial fibrillation and stroke: a practical guide. Pract Neurol. 2019;19(3):208–224. doi:10.1136/practneurol-2018-00208930826740
   PubMedGoogle Scholar
• Tse HF, Wang YJ, Ahmed Ai-Abdullah M, et al. Stroke prevention in atrial fibrillation–an Asian stroke perspective. Heart Rhythm. 2013;10(7):1082–1088. doi:10.1016/j.hrthm.2013.03.01723501173
   PubMed Web of Science ®Google Scholar
• Kakkar AK, Mueller I, Bassand JP, et al. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS One. 2013;8(5):e63479. doi:10.1371/journal.pone.006347923704912
   PubMed Web of Science ®Google Scholar
• Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–272. doi:10.1378/chest.09-158419762550
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373–498.32860505
   PubMed Web of Science ®Google Scholar
• Chiang CE, Wang KL, Lip GY. Stroke prevention in atrial fibrillation: an Asian perspective. Thromb Haemost. 2014;111(5):789–797. doi:10.1160/TH13-11-094824500243
   PubMed Web of Science ®Google Scholar
• Krittayaphong R, Winijkul A, Methavigul K, et al. Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study. BMC Cardiovasc Disord. 2018;18(1):174. doi:10.1186/s12872-018-0911-430144802
   PubMed Web of Science ®Google Scholar
• Lip GY, Andreotti F, Fauchier L, et al. Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. Europace. 2011;13(5):723–746. doi:10.1093/europace/eur12621515596
   PubMed Web of Science ®Google Scholar
• Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575–1585.20228401
   PubMed Web of Science ®Google Scholar
• Vidal-Petiot E, Ford I, Greenlaw N, et al. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study. Lancet. 2016;388(10056):2142–2152. doi:10.1016/S0140-6736(16)31326-527590221
   PubMed Web of Science ®Google Scholar
• Wright JT, Williamson JD, Whelton PKet al.; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–2116. doi:10.1056/NEJMoa151193926551272
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104.30165516
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127–e248.29146535
   PubMed Web of Science ®Google Scholar
• Pagonas N, Schmidt S, Eysel J, et al. Impact of atrial fibrillation on the accuracy of oscillometric blood pressure monitoring. Hypertension. 2013;62(3):579–584. doi:10.1161/HYPERTENSIONAHA.113.0142623897073
   PubMed Web of Science ®Google Scholar
• Weber MA, Bakris GL, Hester A, et al. Systolic blood pressure and cardiovascular outcomes during treatment of hypertension. Am J Med. 2013;126(6):501–508. doi:10.1016/j.amjmed.2013.01.00723541376
   PubMed Web of Science ®Google Scholar
• Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–967. doi:10.1016/S0140-6736(15)01225-826724178
   PubMed Web of Science ®Google Scholar
• Clark CE, McDonagh STJ, McManus RJ. Accuracy of automated blood pressure measurements in the presence of atrial fibrillation: systematic review and meta-analysis. J Hum Hypertens. 2019;33(5):352–364. doi:10.1038/s41371-018-0153-z30631126
   PubMed Web of Science ®Google Scholar
• Stergiou GS, Kyriakoulis KG, Stambolliu E, et al. Blood pressure measurement in atrial fibrillation: review and meta-analysis of evidence on accuracy and clinical relevance. J Hypertens. 2019;37(12):2430–2441. doi:10.1097/HJH.000000000000220131408028
   PubMed Web of Science ®Google Scholar
• Bohm M, Brueckmann M, Eikelboom JW, et al. Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial. Eur Heart J. 2020;41(30):2848–2859. doi:10.1093/eurheartj/ehaa24732385506
   PubMed Web of Science ®Google Scholar
• Cooper-DeHoff RM, Gong Y, Handberg EM, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010;304(1):61–68. doi:10.1001/jama.2010.88420606150
   PubMed Web of Science ®Google Scholar
• Ruland S, Aiyagari V. Cerebral autoregulation and blood pressure lowering. Hypertension. 2007;49(5):977–978. doi:10.1161/HYPERTENSIONAHA.107.08750217353508
   PubMed Web of Science ®Google Scholar
• Kim TH, Yang PS, Yu HT, et al. Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population. Eur Heart J. 2019;40(10):809–819. doi:10.1093/eurheartj/ehy87730608537
   PubMed Web of Science ®Google Scholar
• Ishii M, Ogawa H, Unoki T, et al. Relationship of hypertension and systolic blood pressure with the risk of stroke or bleeding in patients with atrial fibrillation: the Fushimi AF registry. Am J Hypertens. 2017;30(11):1073–1082. doi:10.1093/ajh/hpx09428575205
   PubMed Web of Science ®Google Scholar
• Lip GYH. The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol. 2017;14(11):627–628. doi:10.1038/nrcardio.2017.15328960189
   PubMed Web of Science ®Google Scholar
• Agarwal MA, Potukuchi PK, Sumida K, et al. Clinical outcomes of warfarin initiation in advanced chronic kidney disease patients with incident atrial fibrillation. JACC Clin Electrophysiol. 2020;6(13):1658–1668. doi:10.1016/j.jacep.2020.06.03633334444
   PubMedGoogle Scholar